flufenamic acid has been researched along with Hemophilia A in 2 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Von Kaulla, E | 2 |
Von Kaulla, KN | 2 |
2 other studies available for flufenamic acid and Hemophilia A
Article | Year |
---|---|
Factor 8 activity in haemophkilic plasma unmasked by synthetic organic anions.
Topics: Blood Coagulation; Carboxylic Acids; Cinnamates; Factor VIII; Fibrinolytic Agents; Flufenamic Acid; | 1972 |
[Increase of factor VIII-(antihemophilic globulin)-activity in plasma of hemophiliacs following addition of synthetic fibrinolytic compounds].
Topics: Anions; Carbon Dioxide; Factor VIII; Fibrinolysis; Fibrinolytic Agents; Flufenamic Acid; Hemophilia | 1973 |